Obseva Logo highresolution.jpg
ObsEva Announces Delisting from SIX Swiss Exchange and Exemption from Certain Obligations Associated with the Maintenance of Listin
April 03, 2024 01:00 ET | ObsEva SA
Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange GENEVA, Switzerland – April 3, 2024 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing and commercializing novel...
Geojunxion_RGB.png
GeoJunxion closes sale of its entire business, dissolves and will be delisted
January 15, 2024 12:30 ET | GeoJunxion N.V.
This is a joint press release by GeoJunxion N.V. (in liquidation) (GeoJunxion) and Road Runner B.V. in connection with (i) the completion of the announced sale of all issued and outstanding ordinary...
Geojunxion_RGB.png
GeoJunxion NV (GOJXN.AS) heeft de kennisgeving van Euronext ontvangen over het begin van het schrapproces
May 04, 2023 12:00 ET | GeoJunxion N.V.
Capelle aan den IJssel, Nederland - 04 mei 2023 - GeoJunxion (GOJXN.AS) heeft het bericht van Euronext ontvangen over de start van het schrapproces overeenkomstig de regels 6905/1 en 6905/2. Zoals...
Geojunxion_RGB.png
GeoJunxion NV (GOJXN.AS) received the Euronext notification about the start of the delisting process
May 04, 2023 12:00 ET | GeoJunxion N.V.
Capelle aan den IJssel, The Netherlands – 04 May 2023 – GeoJunxion (GOJXN.AS) received the Euronext notification about the start of the delisting process in accordance with rules 6905/1 and 6905/2. ...
Full Logo - OKYO .jpg
Notice of General Meeting and Publication of Circular
April 05, 2023 02:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, April 05, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical company which is...
Full Logo - OKYO .jpg
Notice of Intention to Delist From The London Stock Exchange
April 04, 2023 02:00 ET | OKYO Pharma LTD
LONDON and NEW YORK, April 04, 2023 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (Nasdaq: OKYO; LSE: OKYO) ("OKYO" or the "Company"), an ophthalmology-focused bio-pharmaceutical company which is...
sonlogo.jpg
Sonasoft Corp. Announces Intention to Voluntarily Delist
February 15, 2023 16:00 ET | Sonasoft Corp.
SAN JOSE, CA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Today, Sonasoft Corp., a California Corporation, (OTCQB: SSFT) (“Sonasoft” or the “Company”) announced its intent to voluntarily...
Hylands International Announces Voluntary Delisting of Shares
October 07, 2022 17:01 ET | Hylands International Holdings Inc.
TORONTO, Oct. 07, 2022 (GLOBE NEWSWIRE) -- Hylands International Holdings Inc. (TSXV: HIH; “Hylands” or the “Company”) announced today that the Company has requested the delisting of its common...
logo.jpg
Delisting of GrandVision on 10 January 2022
December 13, 2021 12:00 ET | GrandVision Retail Holding B.V.
Delisting of GrandVision on 10 January 2022 Settlement of the Offer took place on 8 December 2021 Post-Acceptance Period will end on 20 December 2021 The last trading date of the Shares...
ASLAN Pharmaceuticals Announces the Move of its Primary Listing to Nasdaq and Delisting From Taipei Exchange
July 17, 2020 06:08 ET | ASLAN PHARMACEUTICALS LIMITED
SINGAPORE, July 17, 2020 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN, TPEx:6497), a clinical-stage immunology and oncology focused biopharmaceutical company developing innovative...